247 related articles for article (PubMed ID: 21390570)
1. Crosstalk of TGF-β and estrogen receptor signaling in breast cancer.
Band AM; Laiho M
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):109-15. PubMed ID: 21390570
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor alpha attenuates transforming growth factor-beta signaling in breast cancer cells independent from agonistic and antagonistic ligands.
Stope MB; Popp SL; Knabbe C; Buck MB
Breast Cancer Res Treat; 2010 Apr; 120(2):357-67. PubMed ID: 19370415
[TBL] [Abstract][Full Text] [Related]
3. Estrogen inhibits transforming growth factor beta signaling by promoting Smad2/3 degradation.
Ito I; Hanyu A; Wayama M; Goto N; Katsuno Y; Kawasaki S; Nakajima Y; Kajiro M; Komatsu Y; Fujimura A; Hirota R; Murayama A; Kimura K; Imamura T; Yanagisawa J
J Biol Chem; 2010 May; 285(19):14747-55. PubMed ID: 20207742
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-β signaling pathway cross-talking with ERα signaling pathway on regulating the growth of uterine leiomyoma activated by phenolic environmental estrogens in vitro.
Shen Y; Wu Y; Lu Q; Zhang P; Ren M
Tumour Biol; 2016 Jan; 37(1):455-62. PubMed ID: 26224478
[TBL] [Abstract][Full Text] [Related]
5. Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.
Petrel TA; Brueggemeier RW
J Cell Biochem; 2003 Jan; 88(1):181-90. PubMed ID: 12461787
[TBL] [Abstract][Full Text] [Related]
6. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.
Liu BW; Yu ZH; Chen AX; Chi JR; Ge J; Yu Y; Cao XC
J Exp Clin Cancer Res; 2019 Mar; 38(1):109. PubMed ID: 30823890
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-455-3p mediates GATA3 tumor suppression in mammary epithelial cells by inhibiting TGF-β signaling.
Zeng Y; Gao T; Huang W; Yang Y; Qiu R; Hou Y; Yu W; Leng S; Feng D; Liu W; Teng X; Yu H; Wang Y
J Biol Chem; 2019 Oct; 294(43):15808-15825. PubMed ID: 31492753
[TBL] [Abstract][Full Text] [Related]
9. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
10. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
[TBL] [Abstract][Full Text] [Related]
11. Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.
Matise LA; Palmer TD; Ashby WJ; Nashabi A; Chytil A; Aakre M; Pickup MW; Gorska AE; Zijlstra A; Moses HL
Breast Cancer Res; 2012 Jul; 14(4):R98. PubMed ID: 22748014
[TBL] [Abstract][Full Text] [Related]
12. Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.
Brattain MG; Ko Y; Banerji SS; Wu G; Willson JK
J Mammary Gland Biol Neoplasia; 1996 Oct; 1(4):365-72. PubMed ID: 10887510
[TBL] [Abstract][Full Text] [Related]
13. Dual effects of TGF-beta on ERalpha-mediated estrogenic transcriptional activity in breast cancer.
Ren Y; Wu L; Frost AR; Grizzle W; Cao X; Wan M
Mol Cancer; 2009 Nov; 8():111. PubMed ID: 19943940
[TBL] [Abstract][Full Text] [Related]
14. Noncanonical TGF-β signaling during mammary tumorigenesis.
Parvani JG; Taylor MA; Schiemann WP
J Mammary Gland Biol Neoplasia; 2011 Jun; 16(2):127-46. PubMed ID: 21448580
[TBL] [Abstract][Full Text] [Related]
15. Bergapten induces ER depletion in breast cancer cells through SMAD4-mediated ubiquitination.
Panno ML; Giordano F; Rizza P; Pellegrino M; Zito D; Giordano C; Mauro L; Catalano S; Aquila S; Sisci D; De Amicis F; Vivacqua A; Fuqua SW; Andò S
Breast Cancer Res Treat; 2012 Nov; 136(2):443-55. PubMed ID: 23053665
[TBL] [Abstract][Full Text] [Related]
16. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
Rao X; Di Leva G; Li M; Fang F; Devlin C; Hartman-Frey C; Burow ME; Ivan M; Croce CM; Nephew KP
Oncogene; 2011 Mar; 30(9):1082-97. PubMed ID: 21057537
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor-α signaling in post-natal mammary development and breast cancers.
Rusidzé M; Adlanmérini M; Chantalat E; Raymond-Letron I; Cayre S; Arnal JF; Deugnier MA; Lenfant F
Cell Mol Life Sci; 2021 Aug; 78(15):5681-5705. PubMed ID: 34156490
[TBL] [Abstract][Full Text] [Related]
19. Autocrine regulation of cell proliferation by estrogen receptor-alpha in estrogen receptor-alpha-positive breast cancer cell lines.
Tan H; Zhong Y; Pan Z
BMC Cancer; 2009 Jan; 9():31. PubMed ID: 19171042
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta signaling in mammary gland development and tumorigenesis.
Wakefield LM; Piek E; Böttinger EP
J Mammary Gland Biol Neoplasia; 2001 Jan; 6(1):67-82. PubMed ID: 11467453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
